Thank you to our speakers, sponsors, and delegates who joined us in Washington for the summit! If you are interested in the 2026 event, please get in touch at info@hansonwade.com

Implement Effective Payment Models, Establish Value & Advance Reimbursement Strategies Across Inpatient and Outpatient Settings to Improve Cell & Gene Therapy Coverage

Welcome to the Cell & Gene Therapy Pricing & Reimbursement Summit!

Current limitations across pricing, coverage, and payment frameworks are lasering out and hindering global access to many approved cell and gene therapies (CGTs). The Cell & Gene Therapy Pricing & Reimbursement Summit is here to change that. 

Returned for its 2nd edition, this unique summit shared real-world case studies of success and setback in ensuring patients can access CGTs to spearhead reform in this thorny landscape.

Industry-led discussions centered on innovative payment models being developed and applied, new stop-loss and reinsurance programs, and how leading companies are ensuring coverage and uptake of their commercialized therapies. You have left with actionable learnings from recent CMS policy changes, including the Access Model, Medicaid Drug Rebate Program Final Rule, and proposed increases to inpatient CAR-T reimbursement rates.

Leaders from biopharma, government agencies, commercial payers, academics, and market access-specialist service providers came together to align on the current market access strategy and policy challenges that had been hindering widespread adoption of these ground-breaking therapies. The summit aimed to enhance your payer coverage and improve patient access.

2025 Expert Speaker Faculty Included:

2025 Lead Partner

Artia Solutions Logo

Expertise Partners

Uniphar
Milliman Logo - Our Partner

Hosting Partners

Red Nucleus logo
Occam Health Services

Innovation Partner

GuideHouse logo

Event Partners

Digital health Policy Strategies logo
Lyfegen_Logotype_Black-RGB

Who Attended In 2024?

2024's Attending Companies

Testimonials

Copy of Untitled Design (5)

"Expert speakers and highly relevant in-depth content."

Miltenyi Biotech 

Copy of Untitled Design (6)

"The information provided, particularly from the different payers, was extremely useful for understanding what issues and mindsets we will have to overcome."

UCB

Copy of Untitled Design (4)

"Great line up of speakers, very relevant topics and actionable insights."

Neurogene